1-4 of 4
Heather Powell, MS
Close
Sort by
Journal Articles

Concomitant Myelofibrosis and Plasma Cell Disorders: The Mayo Clinic Experience.

Ruben A. Mesa, MD, S. Vincent Rajkumar, MD, Susan Schwager, Rebecca McClure, MD, Heather Powell, MS, Terra Lasho, Robert A. Kyle, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2006) 108 (11): 3603.
https://doi.org/10.1182/blood.V108.11.3603.3603
Published: 2006
Journal Articles

JAK2 V617F Mutational Status in Myelofibrosis at and before Disease Progression Including Leukemic Transformation: A Longitudinal Study in 68 Patients.

Ruben A. Mesa, MD, Heather Powell, MS, Terra Lasho, BS, Ayalew Tefferi, MD
Journal: Blood
Blood (2005) 106 (11): 2575.
https://doi.org/10.1182/blood.V106.11.2575.2575
Published: 2005
Journal Articles

JAK2 (V617F) Mutation Status and Neutrophil Apoptotic Resistance in Myelofibrosis with Myeloid Metaplasia (MMM): Correlation and Potential Identification through Phosphorylation Status of STAT3.

Ruben A. Mesa, MD, Ayalew Tefferi, MD, Heather Powell, MS, Terra Lasho, BS, David Loegering, BS, Scott H. Kaufmann, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3503.
https://doi.org/10.1182/blood.V106.11.3503.3503
Published: 2005
Journal Articles

Evaluation of the In Vitro Activity of the Multikinase Inhibitor BAY 43-9006 (Sorafenib) in Primary Cells from Patients with Myelofibrosis with Myeloid Metaplasia (MMM).

Joseph W. Smith, BS, Heather Powell, MS, Ayalew Tefferi, MD, Scott H. Kaufmann, MD, PhD, Terra Lasho, BS, David Loegerling, Marina Galvez, Ruben Mesa, MD
Journal: Blood
Blood (2005) 106 (11): 4943.
https://doi.org/10.1182/blood.V106.11.4943.4943
Published: 2005